The board of directors of United Gene High-Tech Group Limited appointed on October 25, 2013 of Dr. Yu Wei Ping as Adviser and Joint chairman to the Department of Innovation and Strategic Development of the company. Dr. Yu, aged 55, shall utilize his pharmaceutical experience to provide innovation and strategy consultation in the pharmaceutical industry to the company and its subsidiaries in relation to research and development of the Group's pharmaceutical and biotechnological related projects and products as well as other scientific technologies. He shall report to the Board.
Innovative Pharmaceutical Biotech Limited
Equities
399
BMG4783W1073
Industrial Machinery & Equipment
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.195 HKD | 0.00% | +1.04% | -10.96% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.96% | 43.09M | |
+14.88% | 46.78B | |
+1.94% | 38.17B | |
+15.96% | 7.76B | |
+17.53% | 7.17B | |
-9.68% | 5.21B | |
+16.06% | 1.72B | |
+25.44% | 1.49B | |
-2.17% | 1.35B | |
+23.89% | 1.16B |
- Stock Market
- Equities
- 399 Stock
- News Innovative Pharmaceutical Biotech Limited
- United Gene High-Tech Group Limited Appoints Dr. Yu Wei Ping as Adviser and Joint chairman to the Department of Innovation and Strategic Development